Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 216 of 216 entries
View as:

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04545385 Org: User:
Start: 10/07/20 End: 01/17/22 Due: 01/17/23

Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT01783548 Org: User:
Start: 01/31/13 End: 10/31/13 Due: 10/31/14

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02284568 Org: User:
Start: 01/12/15 End: 10/01/17 Due: 10/01/18

A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01758978 Org: User:
Start: 12/31/12 End: 01/31/13 Due: 01/31/14

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Phase: N/A Priority: Normal
NCT ID: NCT00203073 Org: User:
Start: 06/30/03 End: 04/30/05 Due: 04/30/06

Non-invasive Measures of Distal Lung Disease in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00250341 Org: User:
Start: 09/30/05 End: 09/30/07 Due: 09/30/08

Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®

Phase: N/A Priority: Normal
NCT ID: NCT02499900 Org: User:
Start: 08/10/15 End: 06/02/17 Due: 06/02/18

Effects of Talampanel on Patients With Advanced Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00036296 Org: User:
Start: 12/31/06 End: 02/28/07 Due: 02/28/08

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04677959 Org: User:
Start: 02/16/21 End: 03/10/22 Due: 03/10/23

Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)

Phase: N/A Priority: Normal
NCT ID: NCT01133626 Org: User:
Start: 06/30/10 End: 09/30/10 Due: 09/30/11

A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Phase: N/A Priority: Normal
NCT ID: NCT03347188 Org: User:
Start: 12/18/17 End: 06/03/20 Due: 06/03/21

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00112411 Org: User:
Start: 06/30/05 End: 09/30/05 Due: 09/30/06

A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01067521 Org: User:
Start: 06/22/10 End: 05/12/17 Due: 05/12/18

Mass Balance Clinical Trial With TEV-56286

Phase: N/A Priority: Normal
NCT ID: NCT06627231 Org: User:
Start: 10/08/24 End: 11/29/24 Due: 11/29/25

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties

Phase: N/A Priority: Normal
NCT ID: NCT00932581 Org: User:
Start: 06/30/09 End: 12/31/09 Due: 12/31/10

A Double-blind, Randomized Controlled Study in CD20-positive Diffuse B Cell Non-Hodgkin's Lymphoma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01205737 Org: User:
Start: 09/30/10 End: 09/30/13 Due: 09/30/14